Aptus Pharma Limited (BOM:544529)
339.90
+6.65 (2.00%)
At close: Sep 11, 2026
Aptus Pharma Market Cap
Aptus Pharma has a market cap or net worth of 5.83 billion as of September 14, 2026.
Market Cap
5.83B
Enterprise Value
5.89B
Revenue
465.75M
Ranking
n/a
PE Ratio
109.22
Stock Price
339.90
ChartMarket Cap Chart
Since September 30, 2025, Aptus Pharma's market cap has increased from 582.00M to 5.83B, an increase of 901.59%. That is a compound annual growth rate of 1,036.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 5.83B | 401.33% |
| Dec 31, 2025 | 1.16B | 99.79% |
| Sep 30, 2025 | 582.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arvaya Healthcare | 5.86B |
| Khemani Distributors & Marketing | 2.61B |
| Novelix Pharmaceuticals | 2.21B |
| Chemkart India | 1.98B |
| Rama Vision | 1.81B |
| Achyut Healthcare | 1.68B |
| VijayPD Ceutical | 1.27B |
| Constronics Infra | 621.19M |